Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 22, Issue 1, Pages 275
Publisher
Baishideng Publishing Group Inc.
Online
2015-12-31
DOI
10.3748/wjg.v22.i1.275
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches
- (2015) Tim F Greten et al. GUT
- High preoperative levels of serum glypican-3 containing N-terminal subunit are associated with poor prognosis in patients with hepatocellular carcinoma after partial hepatectomy
- (2015) Yukihiro Haruyama et al. INTERNATIONAL JOURNAL OF CANCER
- Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway
- (2015) YONGLE WU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The interaction of anticancer therapies with tumor-associated macrophages
- (2015) Alberto Mantovani et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis
- (2015) Wei Gao et al. Nature Communications
- miR-126 inhibits cell proliferation and induces cell apoptosis of hepatocellular carcinoma cells partially by targeting Sox2
- (2015) Chunfang Zhao et al. Human Cell
- The “Macro” World of microRNAs in Hepatocellular Carcinoma
- (2015) Kaveri Sidhu et al. Frontiers in Oncology
- Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells
- (2015) Wei Gao et al. PLoS One
- Discovery and Diagnostic Value of a Novel Oncofetal Protein
- (2014) Sean K. Wang et al. ADVANCES IN ANATOMIC PATHOLOGY
- Prognostic significance of glypican-3 in hepatocellular carcinoma: a meta-analysis
- (2014) Wei-Kai Xiao et al. BMC CANCER
- Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma
- (2014) Masafumi Ikeda et al. CANCER SCIENCE
- Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
- (2014) H. Gao et al. CLINICAL CANCER RESEARCH
- Can Serum Glypican-3 Be a Biomarker for Effective Diagnosis of Hepatocellular Carcinoma? A Meta-Analysis of the Literature
- (2014) Sheng-Li Yang et al. DISEASE MARKERS
- Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment
- (2014) Gianluigi Giannelli et al. GUT
- Clinical Utility of Plasma Glypican-3 and Osteopontin as Biomarkers of Hepatocellular Carcinoma
- (2014) Hyun Jung Lee et al. Gut and Liver
- Establishment and biological characterization of a novel cell line derived from hepatoid adenocarcinoma originated at the ampulla of Vater
- (2014) NOBUYASU TAKAHASHI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma
- (2014) Akinobu Ohno et al. LIVER INTERNATIONAL
- Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth
- (2014) Ubaldo E. Martinez-Outschoorn et al. SEMINARS IN CANCER BIOLOGY
- Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: A meta-analysis
- (2014) Jia Li WORLD JOURNAL OF GASTROENTEROLOGY
- SMAC-armed vaccinia virus induces both apoptosis and necroptosis and synergizes the efficiency of vinblastine in HCC
- (2014) Qiang Pan et al. Human Cell
- Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma
- (2013) Min Chen et al. CLINICA CHIMICA ACTA
- First-in-Man Phase I Study of GC33, a Novel Recombinant Humanized Antibody Against Glypican-3, in Patients with Advanced Hepatocellular Carcinoma
- (2013) A. X. Zhu et al. CLINICAL CANCER RESEARCH
- Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma
- (2013) Jorge Filmus et al. FEBS Journal
- Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma
- (2013) M. Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection
- (2013) Shun-Jun Fu et al. SURGERY
- Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma
- (2012) Li Li et al. HEPATOLOGY
- Hepatoid carcinoma of the pancreas penetrating into the gastric cavity: A case report and literature review
- (2012) Keita Kai et al. PATHOLOGY INTERNATIONAL
- Glypican-3 expression and its relationship with recurrence of HCC after liver transplantation
- (2012) Yu-Liang Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Histologic and Immunohistochemical Analyses of α-Fetoprotein—Producing Cancer of the Stomach
- (2011) Tetsu Kinjo et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Recurrence and Poor Prognosis Following Resection of Small Hepatitis B-Related Hepatocellular Carcinoma Lesions Are Associated with Aberrant Tumor Expression Profiles of Glypican 3 and Osteopontin
- (2011) Ming-Chin Yu et al. ANNALS OF SURGICAL ONCOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Simultaneous Measurements of Serum AFP, GPC-3 and HCCR for Diagnosing Hepatocellular Carcinoma
- (2011) Shi-Shi Qiao et al. HEPATO-GASTROENTEROLOGY
- Diagnostic and prognostic role of serum glypican 3 in patients with hepatocellular carcinoma
- (2011) Hasan Özkan et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Glypican-3, a novel prognostic marker of hepatocellular cancer, is related with postoperative metastasis and recurrence in hepatocellular cancer patients
- (2011) Su Ning et al. MOLECULAR BIOLOGY REPORTS
- The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation
- (2010) Jin-Ping Lai et al. HEPATOLOGY
- Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma
- (2010) Eisuke Yasuda et al. HEPATOLOGY RESEARCH
- Prognostic significance of circumferential cell surface immunoreactivity of glypican-3 in hepatocellular carcinoma
- (2010) Kenji Yorita et al. LIVER INTERNATIONAL
- Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma
- (2010) Hui Liu WORLD JOURNAL OF GASTROENTEROLOGY
- Optimization of tissue processing for immunohistochemistry for the detection of human glypican-3
- (2009) Hirotake Takai et al. ACTA HISTOCHEMICA
- Epithelial-Mesenchymal Transition
- (2009) Michael W. Klymkowsky et al. AMERICAN JOURNAL OF PATHOLOGY
- Glypican 3-expressing gastric carcinoma: Distinct subgroup unifying hepatoid, clear-cell, and α-fetoprotein-producing gastric carcinomas
- (2009) Tetsuo Ushiku et al. CANCER SCIENCE
- Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma
- (2009) Hirofumi Shirakawa et al. CANCER SCIENCE
- Soluble glypican 3 inhibits the growth of hepatocellular carcinomain vitroandin vivo
- (2009) Sandra I. Zittermann et al. INTERNATIONAL JOURNAL OF CANCER
- Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers
- (2009) Pisit Tangkijvanich et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The expression profile of glypican-3 and its relation to macrophage population in human hepatocellular carcinoma
- (2009) Hirotake Takai et al. LIVER INTERNATIONAL
- Glypican-3 expression in clear cell adenocarcinoma of the ovary
- (2009) Daichi Maeda et al. MODERN PATHOLOGY
- Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells
- (2008) Kiyotaka Nakano et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mammalian Notum induces the release of glypicans and other GPI-anchored proteins from the cell surface
- (2008) Alexandra Traister et al. BIOCHEMICAL JOURNAL
- AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease
- (2008) Gary Beale et al. BMC CANCER
- Anti-Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer
- (2008) T. Ishiguro et al. CANCER RESEARCH
- Glypican-3 Inhibits Hedgehog Signaling during Development by Competing with Patched for Hedgehog Binding
- (2008) Mariana I. Capurro et al. DEVELOPMENTAL CELL
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glypicans
- (2008) Jorge Filmus et al. GENOME BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started